AstraZeneca shots have good risk-benefit profile for over 60s, says EMA official
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
AstraZeneca shots have good risk-benefit profile for over 60s, says EMA official

Coronavirus chronicle

Reuters
14 June, 2021, 08:55 am
Last modified: 14 June, 2021, 09:00 am

Related News

  • AstraZeneca Covid drug neutralises Omicron sub-variants in study
  • Short AstraZeneca shelf life complicates Covid vaccine rollout to world's poorest
  • France donates 2.12 million more AstraZeneca shots to Bangladesh
  • New data finds AstraZeneca booster generates higher antibodies against Omicron
  • Nigeria destroys 1 mln donated AstraZeneca vaccines with short shelf life

AstraZeneca shots have good risk-benefit profile for over 60s, says EMA official

Italian newspaper La Stampa earlier quoted European Medicines Agency (EMA) task force chief Marco Cavaleri as saying countries should avoid giving the vaccine to people aged over 60 in addition to younger age groups, amid fears over very rare blood clotting and as alternative vaccines become available

Reuters
14 June, 2021, 08:55 am
Last modified: 14 June, 2021, 09:00 am
Syringes with AstraZeneca coronavirus disease (COVID-19) vaccines are prepared in Fasano Italy, April 13, 2021. REUTERS/Alessandro Garofalo
Syringes with AstraZeneca coronavirus disease (COVID-19) vaccines are prepared in Fasano Italy, April 13, 2021. REUTERS/Alessandro Garofalo

The head of the EU drug regulator's Covid-19 task force said on Sunday that AstraZeneca's (AZN.L) coronavirus vaccine had a favourable risk-benefit profile for all age groups and particularly for those aged over 60.

Italian newspaper La Stampa earlier quoted European Medicines Agency (EMA) task force chief Marco Cavaleri as saying countries should avoid giving the vaccine to people aged over 60 in addition to younger age groups, amid fears over very rare blood clotting and as alternative vaccines become available.

"Unfortunately my words have not been interpreted correctly in a recent interview with La Stampa," Cavaleri said in a statement to Reuters. The AstraZeneca shot "maintains a favourable benefit risk profile in all ages but particularly in the elderly above 60," he said.

The EMA's position is that the AstraZeneca shot is safe and can be used for all age groups over 18. However several European Union member states have stopped administering it to people below a certain age, usually ranging from 50 to 65, restricting its use to older people, due to very rare cases of blood clotting, mainly among young people.

On Sunday evening, La Stampa changed the headline on its article online and added a clarification with Cavaleri's later comments to its article. La Stampa editor Massimo Giannini said he had no further comment.

Earlier this week the Italian government said it would restrict the use of the AstraZeneca vaccine to people aged over 60, after a teenager who had received the shot died from a rare form of blood clotting.

Italian Health Minister Roberto Speranza told reporters on Sunday that Italy will continue to use the AstraZeneca vaccine on the over 60s, including those who have not received a first shot.

Like many European countries, Italy briefly halted AstraZeneca inoculations in March over concerns about the very rare blood clotting problems. It resumed them the following month with the recommendation that the product be "preferably" used for people over the age of 60, after the EMA said its benefits outweighed any risks.

Top News / World+Biz

AstraZeneca / AstraZeneca Covid-19 Vaccine / EMA / risk-benefit

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • What needs to be done now?
    What needs to be done now?
  • File photo of Dr Debapriya Bhattacharya. Picture: CPD
    Fiscal consolidation is a way out
  • Safety net needs to be expanded by minimising corruption 
    Safety net needs to be expanded by minimising corruption 

MOST VIEWED

  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • North Korean leader Kim Jong Un presides over a politburo meeting of the ruling Workers' Party, amid the coronavirus disease (COVID-19) pandemic, May 17, 2022, in this photo released May 18, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS
    N Korean leader slams officials' 'immaturity' in response to Covid outbreak
  • North Korea Covid outbreak is 'worrying' for new variants -WHO
    North Korea Covid outbreak is 'worrying' for new variants -WHO
  • People watch a TV broadcasting a news report on the coronavirus disease (Covid-19) outbreak in North Korea, at a railway station in Seoul, South Korea on 17 May 2022. Photo: Reuters.
    N Korea Covid outbreak could have 'devastating' impact on human rights, UN says

Related News

  • AstraZeneca Covid drug neutralises Omicron sub-variants in study
  • Short AstraZeneca shelf life complicates Covid vaccine rollout to world's poorest
  • France donates 2.12 million more AstraZeneca shots to Bangladesh
  • New data finds AstraZeneca booster generates higher antibodies against Omicron
  • Nigeria destroys 1 mln donated AstraZeneca vaccines with short shelf life

Features

Sketch: TBS

'Food inflation is an unavoidable consequence of currency devaluation'

17h | Interviews
The open-browser-tabs question also tells an interviewer how much of an internet native the job applicant might be. Photo: Noor-a-Alam

The best question to ask a job applicant

17h | Pursuit
Illustration: TBS

Ugly business: Politics in workplace

16h | Pursuit
Illustration: TBS

‘Do you have insurance?’: Life of a life insurance agent

19h | Panorama

More Videos from TBS

Putin's strategies to face Nato

Putin's strategies to face Nato

6h | Videos
How many countries have nuclear weapons and how many are there?

How many countries have nuclear weapons and how many are there?

6h | Videos
Dengue fever is rising, so beware

Dengue fever is rising, so beware

6h | Videos
How a university teacher and PHD holder become farmer

How a university teacher and PHD holder become farmer

11h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab